Using Stock As Currency

As noted in The 10b-5 Daily’s discussions of the Intergroup and NUI decisions, the idea that corporate acquisitions for stock are a sufficient motive for securities fraud is controversial. A contrary view can be found in the recent decision in In re Corning Sec. Litig., 2004 WL 1056063 (W.D.N.Y. April 9, 2004).

In the Corning case, the plaintiffs alleged that the defendants were motivated to artificially inflate the company’s stock price so that they could use it as currency for the acquisition of Tropel Corporation. The court found that “[p]aying a smaller price for the acquisition of Tropel [by using inflated stock] benefited Corning’s common shareholders.” Moreover, the desire to have a high stock price to be used in the purchase of Tropel “is a motive that could be attributed to virtually every company seeking to acquire another through the use of its own stock as part of the purchase.” As a result, the court held that the acquisition failed to create a strong inference of scienter.

Holding: Motion to dismiss granted.

Leave a comment

Filed under Motion To Dismiss Monitor

Providian Settles

Providian Financial Corp. (NYSE: PVN), a San Francisco-based provider of consumer credit cards, has announced the preliminary settlement of the securities class action pending against the company in the N.D. of Cal. The suit, originally filed in 2001 and about to go to trial, alleges that the company made misrepresentations concerning its operations and prospects. The settlement is for $65 million, to be paid by Providian’s insurance carriers.

Leave a comment

Filed under Settlement

Honeywell and Symbol Technologies Settle

Two large settlements from the end of last week:

Honeywell Int’l, Inc. (NYSE: HON), a New Jersey-based diversified manufacturer, has announced the preliminary settlement of the securities class action pending against the company in the D. of N.J. The suit, originally filed in 2002 and currently in discovery, alleges that Honeywell made false and misleading statements relating to the 1999 AlliedSignal/Honeywell merger and its financial performance. Under the terms of the settlement, Honeywell has agreed to pay $100 million into an escrow fund, with $85 million coming from its insurers.

Symbol Technologies, Inc. (NYSE: SBL), a New York-based manufacturer of bar scanner-integrated mobile and wireless information management systems, has announced the preliminary settlement of the securities class action pending against the company in the E.D.N.Y. (as well as settlements with the DOJ and SEC). The suit, originally filed in 2002, alleges that the company made false and misleading statements relating to accounting issues. The settlement is valued at $139 million, including $96.25 million in common stock, $5.75 million in cash (from the company and its ex-CEO), and $37 million in cash from the company as part of a joint compensation fund created in the DOJ settlement. Lead counsel for the class has also issued a press release.

Leave a comment

Filed under Settlement

The Perfect Storm Redux

Are two opinions a trend? Last year, The 10b-5 Daily posted about the denial of the motion to dismiss in the Interpublic Group securities litigation in the S.D.N.Y. The court’s opinion in that case was based on the following controversial legal propositions: (1) Section 20(a) claims have no scienter pleading requirement; (2) corporate acquisitions for stock can be a motive for securities fraud; and (3) companies can be personified for scienter purposes (i.e., a finding of fraudulent intent). In a holding that was described here as “the perfect storm that happens when these three strands of questionable law come together,” the Interpublic court found that even though the plaintiffs had failed to establish a strong inference of scienter for any of Interpublic’s officers, the case could proceed against Interpublic and its officers based on the company’s alleged motive to commit fraud and control person liability.

A year later, another court has issued a very similar decision. In In re NUI Sec. Litig., 2004 WL 895846 (D.N.J. April 23, 2004), the court found that the plaintiffs had adequately alleged a strong inference of scienter for the corporate defendant based on two sets of facts applicable to different parts of the class period. First, NUI’s stock-for-stock acquisition of another company allegedly gave it a motive to inflate the price of its stock. Second, NUI’s associate general counsel (who is not a defendant in the case) was alleged to have actual knowledge of the company’s fraudulent conduct. As to the individual defendants (the CEO and CFO of NUI), however, the court held that there were insufficient allegations concerning their motive to commit fraud and knowledge of the alleged fraudulent conduct. Just as in Interpublic, the Rule 10b-5 claims were allowed to continue against NUI, but were dismissed against the individual defendants. The individual defendants were not, however, free to go. Since they controlled NUI and the court had found that a Rule 10b-5 claim was adequately pled against NUI, the Section 20(a) claims against the individual defendants based on control person liability still remain.

The NUI decision, like the Interpublic decision, would appear to eviscerate the PSLRA’s requirement that scienter be adequately plead as to each defendant. Moreover, the NUI court adds a fourth strand of questionable law to the mix. As recently discussed at length in the Fifth Circuit’s decision in Southland Sec. Corp. v. INSpire Ins. Solutions, Inc., 365 F.3d 353 (5th Cir. 2004), in determining whether a corporate defendant has acted with scienter, a court generally looks “to the state of mind of the individual corporate official or official who make or issue the statement (or order or approve it or its making or issuance, or who furnish information or language for inclusions therein, or the like) rather than generally to the collective knowledge of all the corporation’s officers and employees acquired in the course of their employment.” In other words, courts generally reject a “collective scienter” theory – for example, where a plaintiff attempts to impute the knowledge of the associate general counsel, who is not alleged to have made or issued any statements, to the corporation for scienter purposes. The perfect storm keeps going.

Holding: Motion to dismiss granted in part (as to a separate alleged fraudulent scheme and certain statements), and denied in part.

Leave a comment

Filed under Motion To Dismiss Monitor

Class Action Reform Tabled

As predicted, Senate Majority Leader Bill Frist has been forced to table the Class Action Fairness Act until after the completion of the 2005 Department of Defense authorization bill. The Hill has this report.

Quote of note: “With several of the class-action bill’s co-sponsors opposing the cloture vote, Frist probably lacked the votes yesterday to limit debate on the defense bill. Frist said he remains committed to bringing the class-action bill to the floor and said he would move ‘immediately’ to it after the defense bill was complete.”

Leave a comment

Filed under All The News That's Fit To Blog

U.S. Urges Supreme Court to Resolve Circuit Split on Loss Causation

As The 10b-5 Daily has frequently discussed (indeed, this is the third post in a row on the topic), there is a circuit split over what is necessary to adequately plead loss causation in a securities fraud case. A majority of the courts hold that a plaintiff must demonstrate a causal connection between the alleged misrepresentations and a subsequent decline in the stock price to adequately plead loss causation, while a minority of courts hold that a plaintiff merely needs to demonstrate that the alleged misrepresentations artificially inflated the stock price.

In Broudo v. Dura Pharmaceuticals, Inc., 339 F.3d 933 (9th Cir. 2003), the Ninth Circuit came down firmly in the minority camp. The court found that loss causation “merely requires pleading that the price at the time of purchase was overstated and sufficient identification of the cause.” Based on this holding, the court reversed the lower court’s dismissal and remanded the case for further proceedings. (See this postdiscussing the opinion.) The defendants petitioned for a writ of certiorari to the Supreme Court.

On Friday, the U.S. (the SEC and the Solicitor General) filed an amicus brief in support of the defendants’ petition. In the brief, the U.S. argues that there is “an acknowledged circuit conflict regarding the nature and scope of the plaintiff’s burden to plead and prove loss causation in a fraud-on-the-market case under Rule 10b-5; the court of appeals decided that question incorrectly; the question is one of recurring importance; and this case is a suitable vehicle for resolving it.”

Specifically on the issue of whether the case was incorrectly decided, the U.S. makes two main arguments. First, the U.S. argues that measuring the loss in these types of cases “as of the time of the purchase, and not requiring any allegations of a subsequent loss of value attributable to the fraud, would grant a windfall to investors who sold before the reduction or elimination of the artificial inflation, because they would recover the portion of the purchase price attributable to the fraud on resale, and then would be entitled to recover that same amount again in damages.” Second, the U.S. argues that the decision improperly conflated the separate elements of transaction causation (i.e., the alleged misconduct induced the plaintiff to engage in the transaction in question) and loss causation (i.e., the alleged misconduct caused the plaintiff’s economic loss).

The Supreme Court rarely takes on securities litigation issues. But the combination of a clear circuit split, the U.S.’s encouragement, and yet another opportunity to overturn the Ninth Circuit, may well prove irresistible.

Leave a comment

Filed under Appellate Monitor

PLI Teleseminar On Loss Causation

Regular readers of The 10b-5 Daily know that the past year has seen a series of notable court opinions on the pleading of loss causation (the requirement that a plaintiff demonstrate that the economic harm it suffered occurred as a result of the alleged securities fraud). Is loss causation becoming a significant barrier to bringing a securities fraud claim?

The author of The 10b-5 Daily, Lyle Roberts (Wilson, Sonsini, Goodrich & Rosati), will be chairing a PLI teleseminar on this topic on Wednesday, June 9 at 1 p.m. ET. The panelists are Alfred Lechner (Morgan Lewis & Bockius – former U.S. District Judge) and Sherrie Savett (Berger & Montague). The program will also be webcast and CLE credit is available.

Leave a comment

Filed under All The News That's Fit To Blog

Two Steps To Tango

NERA Economic Consulting has published an interesting working paper entitled “Loss Causation and Damages in Shareholder Class Actions: When It Takes Two Steps To Tango.” The author, Dr. David Tabak, discusses the circuit court split between courts that believe plaintiffs must demonstrate a causal connection between the alleged misrepresentations and a subsequent decline in the stock price to adequately plead loss causation (e.g., Emergent Capital Investment Management, LLC v. Stonepath Group, Inc., 343 F.3d 189 (2d Cir. 2003)) and courts that believe plaintiffs merely need to demonstrate that the alleged misrepresentations artificially inflated the stock price (e.g., Broudo v. Dura Pharmaceuticals, Inc., 339 F.3d 933 (9th Cir. 2003)).

Dr. Tabak finds that “if plaintiffs have to plead either only a purchase inflation or only a later price decline, some investors will ‘successfully’ plead loss causation without having suffered a loss.” Accordingly, there is a logical argument that plaintiffs should have to plead both a purchase inflation and a later price decline related to the fraud to survive a motion to dismiss. The article also discusses how the different loss causation pleading requirements impact the calculation of damages.

Leave a comment

Filed under All The News That's Fit To Blog

Class Action Reform May Be Delayed Again

The Class Action Fairness Act applies some of the reform concepts in the PSLRA and SLUSA to all class actions. Notably, class actions meeting certain jurisdictional criteria would have to be heard in federal court. It is believed that Republicans have enough votes in the Senate to pass the bill, but Reuters reports that there is a disagreement over when it will reach the floor. The House passed its own version of the legislation almost a year ago.

Quote of note: “Republicans seeking curbs on what they call runaway litigation against business want to start debating the class action measure on June 1, when Senate Majority Leader Bill Frist has scheduled a vote on a motion to bring up the bill. . . . But Democratic aides predict Frist will not be able to get the 60 votes he needs to bring up the bill next Tuesday, because of the desire to resume debate on defense.”

Leave a comment

Filed under All The News That's Fit To Blog

PWC Settles Raytheon Suit

In the wake of Raytheon’s settlement of the securities class action pending against the company in the D. of Mass. for $410 million in cash and securities, its co-defendant and former auditor, PricewaterhouseCoopers LLP, also has decided to avoid a trial. The Boston Globe has a lengthy article on PwC’s agreement to pay $50 million to settle its portion of the suit, which alleged that the auditor helped Raytheon hide cost overruns. Taken together, the Raytheon settlements are the fifth-largest ever in a securities class action.

Quote of note: “The settlement allows Raytheon and PwC to put the dark days of 1999 behind them. But the biggest winners in the case may be the jurors who faced the prospect of sifting through complex and highly technical evidence for six weeks or longer. Instead, just after the jury was led in yesterday morning, Judge Saris disclosed the settlement before lightheartedly admonishing the jurors: ‘Don’t look so happy!'”

Leave a comment

Filed under Settlement